MetLife, Inc. $MET Stock Sold by International Assets Investment Management LLC

International Assets Investment Management LLC cut its stake in MetLife, Inc. (NYSE:MET – Free Report) by 71.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,038 shares of the financial services provider’s stock after selling 9,908 shares during the quarter. International Assets Investment Management LLC’s holdings in MetLife were worth $381,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Nvwm LLC boosted its stake in MetLife by 655.3% during the 3rd quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 249 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in MetLife during the second quarter valued at approximately $26,000. Burk Holdings LLC bought a new stake in MetLife in the second quarter valued at approximately $27,000. Highland Investment Advisors LLC bought a new stake in MetLife in the second quarter valued at approximately $30,000. Finally, Elevation Wealth Partners LLC increased its stake in MetLife by 123.5% in the third quarter. Elevation Wealth Partners LLC now owns 362 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 200 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Price Performance

Shares of MET opened at $102.97 on Thursday. The stock has a 50 day simple moving average of $98.57 and a 200 day simple moving average of $86.65. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $106.72. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.20 and a current ratio of 0.21. The firm has a market capitalization of $64.71 billion, a PE ratio of 13.43, a P/E/G ratio of 0.97 and a beta of 0.79.

MetLife (NYSE:MET – Get Free Report) last announced its earnings results on Wednesday, November 4th. The financial services provider reported $2.78 EPS for the quarter, topping the consensus estimate of $2.77 by $0.01. MetLife had a net margin of 6.21% and a return on equity of 25.71%. The firm had revenue of $20.52 billion for the quarter, compared to the consensus estimate of $19.86 billion. During the same period last year, the company posted $2.34 EPS. The business’s quarterly revenue was up 18.2% on a year-over-year basis. Sell-side analysts predict that MetLife, Inc. will post 9.94 EPS for the current fiscal year.

MetLife announced that its Board of Directors has approved a share repurchase program on Wednesday, August 5th that authorizes the company to buy back $3 billion in shares. This buyback authorization authorizes the financial services provider to buy up to 4.8% of its shares through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be given a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a dividend yield of 2.3%. MetLife’s dividend payout ratio is currently 30.90%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on MET. Argus increased their target price on shares of MetLife from $93.00 to $109.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. Jefferies Financial Group boosted their price target on shares of MetLife from $103.00 to $115.00 and gave the company a “buy” rating in a report on Monday, August 10th. Morgan Stanley upped their price objective on shares of MetLife from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, August 24th. Barclays raised their price objective on MetLife from $97.00 to $111.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. Finally, TD Cowen lifted their target price on MetLife from $110.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, October 21st. Fourteen analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $106.62.

Check Out Our Latest Report on MET

About MetLife

(Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.